Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Lymphoid 3Breast 3Head & Neck 2Gastrointestinal 2Thoracic 1Sarcoma 1Plasma cell 1Dermatologic 1

Conditions

Breast Neoplasms 6Vomiting 4Nausea 3Breast Neoplasms, Male 2Inflammatory Breast Neoplasms 1

Interventions

Aprepitant 6Dexamethasone 4Calcium Dobesilate 4Therapeutics 3Palonosetron 3Granisetron 3Cyclophosphamide 3netupitant 2Yoga 2Sugars 2Psychiatric Rehabilitation 2Ondansetron 2Electroacupuncture 2Duration of Therapy 2stinging nettle lectin 1sinomenine 1peppermint oil 1netupitant, palosentron drug combination 1fosaprepitant 1dexamethasone acetate 1dexamethasone 21-phosphate 1Surveys and Questionnaires 1Prochlorperazine 1Olanzapine 1Massage 1Lactose 1Immunoenzyme Techniques 1Hypnosis 1Hygiene 1Growth Differentiation Factor 15 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Nausea × Palonosetron × Breast × Clear all
NCT03862144 2019-03-05

GIM15-NEPA

Consorzio Oncotech

Phase 2 Completed
150 enrolled
Breast

Breast Neoplasms, Nausea, Vomiting

NCT00343863 2017-07-11

Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in Patients Receiving Doxorubicin Hydrochloride and Cyclophosphamide For Early Stage Breast Cancer

University of Washington

Phase NA Completed
41 enrolled 12 charts
Breast

Breast Neoplasms, Nausea, Vomiting, Breast Neoplasms, Male

NCT00475085 2015-11-10

Prevention of Delayed Nausea A Phase III Double-Blind Placebo-Controlled Clinical Trial

University of Rochester

Phase 3 Completed
1,021 enrolled 10 charts
Breast

Breast Neoplasms, Nausea, Vomiting, Breast Neoplasms, Male, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡